AH 7921 is an N-substituted cyclohexylmethylbenzamide classified as an opioid analgesic with high addictive liability. It acts as a selective u-opioid receptor agonist. Minimal oral effective doses for complete pain suppression by AH 7921 are 1.25 and 13.8 mg/kg for canine and rhesus monkey